• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Canada
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [3358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Erythropoiesis-stimulating agents for anemia of chronic kidney disease: systematic review and economic evaluation
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Polyclonal intravenous immunoglobulin in patients with immune thrombocytopenic purpura: clinical systematic review
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Point-of-care testing in the private sector
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Organizational and economic issues in the management of patients with acute ST-segment elevation myocardial infarction (STEMI)
2008     Institute for Clinical Evaluative Sciences (ICES) ICES report: using data from electronic medical records: theory versus practice
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Screening for diabetic retinopathy in Quebec]
2008     Institute for Clinical Evaluative Sciences (ICES) The impact of not having a primary care physician among people with chronic conditions
2008     Medical Advisory Secretariat (MAS) Aging in the community: summary of evidence-based analyses
2008     Institute for Clinical Evaluative Sciences (ICES) Report on coronary artery bypass surgery in Ontario, fiscal years 2005/06 and 2006/07
2008     Institute for Clinical Evaluative Sciences (ICES) Living and dying in Ontario: an opportunity for improved health information
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Asynchronous telehealth: systematic review of analytic studies and environmental scan of relevant initiatives
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Point-of-care testing in the private sector]
2008     Institute of Health Economics (IHE) Air ambulance transportation with capabilities to provide advanced life support
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Diagnostic performance of techniques used for HER-2 testing in breast cancer]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Use of class 3b and class 4 lasers and intense pulsed light sources for cosmetic procedures in non-medical settings
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Indications for hyperbaric oxygen therapy: update]
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 4 Diagnostic imaging revisited. Adult hospitals of the MUHC.
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Adoption of liquid-based cytology: technological evaluation
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Impact of TAU reports
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting agents for procedural sedation and analgesia in Canadian emergency departments: a review of clinical outcomes and economic evaluation
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of neovascular age-related macular degeneration: systematic drug class review and economic evaluation
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Hip protectors in long-term care: a clinical and cost-effectiveness review and primary economic evaluation
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) FDG-PET to assess infections: a review of the evidence
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Octreotide for endocrine, oncologic, and gastrointestinal disorders: systematic review and budget impact analysis
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) The da Vinci surgical robotic system: a review of the clinical and cost- effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous immunoglobulin for treatment of idiopathic thrombocytopenic purpura: economic and health service impact analyses
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Tele-ophthalmology for detecting eye diseases: clinical and cost-effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Racemic epinephrine for acute respiratory distress: review of role and guidelines for use
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Knee-high versus thigh-high compression devices: a review of the clinical and cost-effectiveness
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Evaluation of the individual placement and support (IPS) model for people with mental problems [Le soutien a l'emploi de type "placement et soutien individuels" pour les personnes atteintes de troubles mentaux graves : sa pertinence pour le Quebec - in French only]
2008     Medical Advisory Secretariat (MAS) Limbal stem cell transplantation: an evidence-based analysis
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions to manage aggressive behavior in long-term care residents: a review of the clinical effectiveness and guidelines
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Fondaparinux versus enoxaparin for the prevention of venous thromboembolism: a comparative clinical and cost-effectiveness review
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Fetal scalp lactate testing to reduce caesarean sections: a review of the clinical and cost-effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Exercise in patients with chronic kidney disease and kidney transplant: a review of the clinical and cost-effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Eculizumab for paroxysmal nocturnal hemoglobinuria: a review of clinical and cost-effectiveness
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Comparison of efficacy, effectiveness and safety of fibrinolysis and primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI)
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnostic tests for delirium: a review of the clinical evidence of accuracy and reliability
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Cryotherapy for non-small cell lung cancer: a review of the clinical effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Closed catheter systems for prevention of urinary tract infections: a review of the clinical effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Brain natriuretic peptide testing for congestive heart failure: a review of the guidelines and clinical and cost-effectiveness
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Anti-psychotics in pediatric patients: a review of the clinical effectiveness, safety, and guidelines
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Antibiotic infused bone cement for orthopedic surgeries: a review of the clinical benefit and harm
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Organizational and economic issues in the management of patients with acute ST-segment elevation myocardial infarction (STEMI)]
2008     Medical Advisory Secretariat (MAS) OHTAC 2003 - 2008 Progress Report- advancing health: evidence-based advice on health technology
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single-use medical devices: clinical, economic, and health services impact
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) PRESS: Peer Review of Electronic Search Strategies
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Minimally invasive arthroplasty in the management of hip arthritic disease: systematic review and economic evaluation
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease.
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Milnacipran for Fibromyalgia
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous Erythropoietin Receptor Activator (Mircera) for Renal Anemia
2008     Institute of Health Economics (IHE) CT and MRI services in Alberta: comparisons with other health care systems
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Home telehealth for chronic disease management
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Granulocyte-colony stimulating factor for antiviral-associated neutropenia: Systematic review and economic evaluation
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomographic colonography for colorectal cancer screening in an average risk population: Systematic review and economic evaluation
2008     Technology Assessment at SickKids (TASK) Caspofungin in the empiric treatment of febrile neutropenia in paediatric patients: A comparison with conventional and liposomal amphotericin B
2008     Medical Advisory Secretariat (MAS) Prevention of falls and fall-related injuries in community-dwelling seniors: an evidence-based analysis
2008     Institute of Health Economics (IHE) Islet transplantation for the treatment of Type 1 diabetes - an update
2008     Medical Advisory Secretariat (MAS) Behavioural interventions for urinary incontinence in community-dwelling seniors: an evidence-based analysis
2008     Medical Advisory Secretariat (MAS) Caregiver- and patient-directed interventions for dementia: an evidence-based analysis
2008     Medical Advisory Secretariat (MAS) Social isolation in community-dwelling seniors: an evidence-based analysis
2008     Medical Advisory Secretariat (MAS) The falls/fractures economic model in Ontario residents aged 65 years and over (FEMOR)
2007     Institute of Health Economics (IHE) Screening newborns for hearing: the use of the automated auditory brainstem response and otoacoustic emissions tests for newborn hearing screening
2007     Institute of Health Economics (IHE) Teleoncology: applications and associated benefits for the adult population
2007     Institute of Health Economics (IHE) Safety and efficacy of inhaled nitric oxide in the management of hypoxemic respiratory failure in adults with acute respiratory distress syndrome
2007     Institute of Health Economics (IHE) Screening newborns for cystic fibrosis
2007     Institute of Health Economics (IHE) Routine preoperative tests - are they necessary?
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Adalimumab, alefacept, efalizumab, etanercept, and infliximab for severe psoriasis vulgaris in adults: budget impact analysis and review of comparative clinical- and cost-effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant human growth hormone for treatment of Turner Syndrome: systematic review and economic evaluation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Thiazide diuretics as first-line treatment for hypertension: meta-analysis and economic evaluation
2007     Medical Advisory Secretariat (MAS) Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Prostaglandin analogues for ophthalmic use: analysis of clinical and cost-effectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous renal replacement therapy in adult patients with acute renal failure: systematic review and economic evaluation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Laparoscopic adjustable gastric banding for weight loss in obese adults:clinical and economic review
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Atypical antipsychotic monotherapy for schizophrenia: clinical review and economic evaluation of first year of treatment
2007     Institute for Clinical Evaluative Sciences (ICES) Effectiveness and safety of drug-eluting stents in Ontario
2007     Institute for Clinical Evaluative Sciences (ICES) Quality assessment of administrative data (QuAAD): an opportunity for enhancing Ontario's health data
2007     Institute for Clinical Evaluative Sciences (ICES) The Ontario Wait Time Strategy: no evidence of an adverse impact on other surgeries
2007     Institute for Clinical Evaluative Sciences (ICES) Diagnostic services in Ontario: descriptive analysis and jurisdictional review
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Lubiprostone
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Sacral nerve stimulation in fecal incontinence
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Waiting times at CHUM 1: diagnostic imaging, hip and knee replacements,cardiac surgery, cancer care and sight restoration
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Comparative overview of cancer control strategies in selected jurisdictions
2007     Medical Advisory Secretariat (MAS) Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Multidetector computed tomography for coronary artery disease screening in asymptomatic populations: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Anal dysplasia screening: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Low-density lipoprotein apheresis: an evidence-based analysis
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [The practice of percutaneous coronary interventions in hospitals without on-site cardiac surgery: review of guidelines and analysis of Quebec data, 1999-2004]
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Population screening for primary open-angle glaucoma
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of costeffectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) The role of hyperbaric oxygen therapy in the management of autism
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2007     Medical Advisory Secretariat (MAS) Systematic review and cost-effectiveness analysis of elective endovascular repair compared to open surgical repair of abdominal aortic aneurysms: Final report
2007     Medical Advisory Secretariat (MAS) Clinical and cost-effectiveness analysis of drug eluting stents compared to bare metal stents for percutaneous coronary interventions in Ontario: final report
2007     Medical Advisory Secretariat (MAS) In-room HEPA cleaners: current and recommended practices
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Capsule colonoscopy: PillCam (TM) colon
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-articular hyaluronic acid (viscosupplementation) for hip osteoarthritis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Nicotine vaccines for smoking cessation